Hrt Financial LP Albireo Pharma, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $792,156 - $1.28 Million	48,539 New	48,539 $939,000
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $245,451 - $493,682	-13,239 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $39,381 - $55,502	-1,645 Reduced 11.05%	13,239 $394,000
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $315,391 - $465,720	14,884 New	14,884 $346,000
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $197,976 - $260,351	-7,236 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.9 - $36.87 $209,120 - $266,791	7,236 New	7,236 $254,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.